Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6750
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors ; volume:4 ; number:1 ; day:27 ; month:7 ; year:2004 ; pages:1-12 ; date:12.2004
BMC biotechnology ; 4, Heft 1 (27.7.2004), 1-12, 12.2004
- Creator
-
Douin, Victorine
- Contributor
-
Bornes, Stephanie
Creancier, Laurent
Rochaix, Philippe
Favre, Gilles
Prats, Anne-Catherine
Couderc, Bettina
SpringerLink (Online service)
- DOI
-
10.1186/1472-6750-4-16
- URN
-
urn:nbn:de:1111-2016072531220
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Douin, Victorine
- Bornes, Stephanie
- Creancier, Laurent
- Rochaix, Philippe
- Favre, Gilles
- Prats, Anne-Catherine
- Couderc, Bettina
- SpringerLink (Online service)
Other Objects (12)
Enhanced gene expression from retroviral vectors
Development of a new bicistronic retroviral vector with strong IRES activity
A new generation of pPRIG-based retroviral vectors
Targeted cell entry of lentiviral vectors
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Production of retroviral vectors in continuous high cell density culture
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Development of short hairpin RNA expression vectors targeting the internal ribosomal entry site of the classical swine fever virus genomic RNA
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Enhanced gene expression from retroviral vectors
Development of a new bicistronic retroviral vector with strong IRES activity
A new generation of pPRIG-based retroviral vectors
Targeted cell entry of lentiviral vectors
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Production of retroviral vectors in continuous high cell density culture
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Development of short hairpin RNA expression vectors targeting the internal ribosomal entry site of the classical swine fever virus genomic RNA
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Enhanced gene expression from retroviral vectors
Development of a new bicistronic retroviral vector with strong IRES activity
A new generation of pPRIG-based retroviral vectors
Targeted cell entry of lentiviral vectors
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Production of retroviral vectors in continuous high cell density culture
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Development of short hairpin RNA expression vectors targeting the internal ribosomal entry site of the classical swine fever virus genomic RNA
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives